Survival outcomes in EIF2AK4 mutation-associated pulmonary arterial hypertension: seeking clarity in contrast
In two patients with PVOD associated with homozygous EIF2AK4 mutations, IPS may act to offload the right ventricle with relative preservation of systemic exercise saturations and a more favourable prognosis. Greater use of CTTE in patients with PVOD as well as PAH with lower lung diffusion capacity may lend insight into the clinical and prognostic relevance of IPS in these patient subgroups with otherwise poor prognosis.
Authors
- Bhavin Rawal
- Aleksander Kempny (ORCID: https://orcid.org/0000-0002-3203-5430)
- Stephen John Wort (ORCID: https://orcid.org/0000-0003-4287-1173)
- Laura Price (ORCID: https://orcid.org/0000-0001-5250-660X)
- Jennie Han (ORCID: https://orcid.org/0000-0002-7089-8923)
- Colm McCabe (ORCID: https://orcid.org/0000-0002-0392-8838)
- Zehra Kadani
Institutions
- Royal Brompton Hospital (GB)
- Imperial College London (GB)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1093/ehjcr/ytae538
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.42